Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 14, 2011


Regulus Therapeutics has appointed Cold Spring Harbor Laboratory researcher Gregory Hannon to its scientific advisory board.

Hannon is a co-founder and scientific adviser of RXi Pharmaceuticals, and previously served on the SAB of Alnylam Pharmaceuticals. He also served as an adviser to Allerca, a company that had been developing a hypoallergenic cat using RNAi.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.